author-photo

Peter Williams

Janssen Pharmaceutica

18

Papers

1143

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

2840. Long-term Efficacy, Safety, and Durability of CAB and RPV as Two Drug Oral Maintenance Therapy: LATTE Week 312 Results

2019 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (7)
A Multiple Dose Phase 1 Assessment of Rilpivirine Long-Acting in a Model of Pre-Exposure Prophylaxis against HIV

2019 AIDS Research and Human Retroviruses
Show All
- Source
- Cite
- Save
Citations (2)
2495. Pharmacokinetics of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injectables in HIV-infected Individuals through 48 Weeks in the FLAIR and ATLAS Phase 3 Studies

2019 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (3)
Design, Formulation, and Evaluation of Novel Dissolving Microarray Patches Containing Rilpivirine for Intravaginal Delivery

2019 Advanced Healthcare Materials
Show All
- Source
- Cite
- Save
Citations (21)
Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension

2018 Journal of Controlled Release
Show All
- Source
- Cite
- Save
Citations (57)
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

2017 The Lancet
Show All
- Source
- Cite
- Save
Citations (281)
Formulation and pharmacology of long-acting rilpivirine.

2015 Current Opinion in Hiv and Aids
Show All
- Source
- Cite
- Save
Citations (53)
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial

2015 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (131)
Correction to: Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission (PLoS Pathog, (2015) 11, [10])

2015 PLOS Pathogens
Show All
- Source
- Cite
- Save
Citations (2)
Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials.

2013 AIDS
Show All
- Source
- Cite
- Save
Citations (114)